Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2013
09/25/2013CN102716084B Fluoxetine hydrochloride liposome solid preparation
09/25/2013CN102698248B Medicine composition prepared from alanyl glutamine and compound amino acid by utilizing spray drying method
09/25/2013CN102670940B Traditional Chinese medicine liniment for treating alopecia areata
09/25/2013CN102657811B Orally administered liquid for treating canker sore
09/25/2013CN102648922B Gamuzhuer medicinal latex preparation and preparation method thereof
09/25/2013CN102631665B Pharmaceutical composition of alanyl glutamine injection and compound amino acid injection
09/25/2013CN102626427B Ginkgo dipyridamole composition and preparation method of preparation thereof
09/25/2013CN102626387B Clopidogrel bisulfate liposome solid preparation
09/25/2013CN102579989B Flunarizine hydrochloride and preparation process thereof
09/25/2013CN102579346B Liposome solid preparation of benazepril/hydrochlorothiazide medicine combination
09/25/2013CN102579345B 厄贝沙坦脂质体固体制剂 Irbesartan solid preparation of liposomes
09/25/2013CN102558158B Hairpin polyamide modified by or free of beta-hydroxyl-gamma-amino acid and preparation method and application
09/25/2013CN102552304B Externally applied medicament for treating mite infection of pets
09/25/2013CN102532250B Przewalsikone A compound with anti-tumor activity and preparation method and application thereof
09/25/2013CN102526001B Indomethacin salt transdermal patch and preparation method thereof
09/25/2013CN102512414B Sultamicittin composition and preparation method thereof
09/25/2013CN102438613B Anti-inflammatory composition containing macrolactin A and derivative thereof as active ingredients
09/25/2013CN102432595B N-indole-1-amides compounds and application of N-indole-1-amides compounds as anti-cancer drugs
09/25/2013CN102429963B Method for preparing ultrafine powder Houyanjing San at normal temperature
09/25/2013CN102429893B Anti-inflammation and anti-allergy canker sore treating medicament and preparation method thereof
09/25/2013CN102423482B preparation method of compound amlodipine-lisinopril tablets
09/25/2013CN102423345B Herpes zoster quickly-curing agent
09/25/2013CN102423249B Medical nursing wet tissue with functions of deodorizing and preventing bedsore and preparation method thereof
09/25/2013CN102391323B Tetrahydro-beta-carboline derivative, preparation method thereof and use thereof
09/25/2013CN102391209B Mesylate cinepazide crystal form II and preparation method thereof
09/25/2013CN102349873B Pharmaceutical compositions based on idazoxan salt or one of polymorphs thereof
09/25/2013CN102321080B Doxazosin mesylate V form crystal, and preparation method and usage thereof
09/25/2013CN102302496B Applications of isoquinoline-type alkaloid and derivatives thereof in preparing medicaments for preventing or treating cervical cancer
09/25/2013CN102302476B Dehydrobufotenine dry power inhaler and preparation method and application thereof
09/25/2013CN102283887B Ointment for treating burn
09/25/2013CN102283829B Anti-malarial medicinal composition and preparation method and application thereof
09/25/2013CN102266522B Anti-allergic nasal drop
09/25/2013CN102266408B Use of gardenia extract and borneol effective ingredients in Chinese medicine preparation for intervening in cutaneous prutitus
09/25/2013CN102260250B (-) doxazosin mesylate type IV crystal as well as preparation method and application thereof
09/25/2013CN102219768B Perylenequinone compounds and their extraction and separation method and use
09/25/2013CN102216271B Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound
09/25/2013CN102176899B Benzimidazole anthelmintic compositions
09/25/2013CN102145011B Composition for preventing and curing diarrhea, preparation method and application of composition
09/25/2013CN102131794B 6-substituted phenoxychroman carboxylic acid derivatives
09/25/2013CN102125568B Medicinal composition containing clopidogrel and aspirin and application thereof to preparation of medicaments for treating acute non-disabling cerebrovascular diseases
09/25/2013CN102099028B A novel standardized composition, method of manufacture and use in the resolution of RNA virus infection
09/25/2013CN102056589B Solid pharmaceutical formulations comprising BIBW 2992
09/25/2013CN102038688B Chlorquinaldol-promestriene vaginal emulsifiable micro-emulsion soft capsule and preparation method thereof
09/25/2013CN102028664B Citicoline sodium tablets and preparation method thereof
09/25/2013CN101932582B Salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
09/25/2013CN101904834B Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition
09/25/2013CN101798300B N-phenylindole methyl substituted bis-benzimidazole derivative and application thereof in reducing blood pressure and the like
09/25/2013CN101781306B Ion-pair compounds of sanguinarine from Chinese herbs extract, and preparation and applications thereof
09/25/2013CN101747316B High-purity strontium ranelate and preparation method thereof
09/25/2013CN101743227B Novel histidine derivative
09/25/2013CN101724016B Peptide compound and preparation method and application thereof
09/25/2013CN101711242B ((Bicylicheteroaryl) imidazolyl) methylheteroaryl compounds as adrenergic receptor agonists
09/25/2013CN101696208B Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with a cyclic amino group as CRF antagonists
09/25/2013CN101679434B 2, 6, 9-substituted purine derivatives having anti proliferative properties
09/25/2013CN101674820B Method of using histone deacetylase inhibitors and monitoring biomarkers in combination therapy
09/25/2013CN101633683B Antihepatitis medicament, preparation method thereof and use thereof
09/25/2013CN101616588B Substituted piperidinophenyl oxazolidinones
09/25/2013CN101601648B Sub-microemulsion used for intravenous injection of polyene yew alcohol phospholipid composite and preparation method thereof
09/25/2013CN101591228B Novel azulene compounds and application thereof
09/25/2013CN101547924B Compounds for inhibiting mitotic progression
09/25/2013CN101475636B Human interferon-like protein and use thereof
09/25/2013CN101309912B Oxazole compound and pharmaceutical composition
09/25/2013CN101293888B Xanthine derivative, production and use thereof as a medicament
09/25/2013CN101239190B Vitamin receptor binding drug delivery conjugates
09/24/2013US8541628 cytofectins; delivering an anionic molecule into a cell by complexing with cationic lipids of invention
09/24/2013US8541620 Method for selectively crystallizing a Z isomer of iopromide
09/24/2013US8541618 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
09/24/2013US8541607 Disulfide, sulfide, sulfoxide, and sulfone derivatives of cyclic sugars and uses thereof
09/24/2013US8541603 Substituted cyclopentanes or cyclopentanones as therapeutic agents
09/24/2013US8541601 Piperazine dithioctate and pharmaceutical composition comprising the same
09/24/2013US8541596 Inhibitors
09/24/2013US8541595 Imidazoisoindole neuropeptide S receptor antagonists
09/24/2013US8541592 Inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1
09/24/2013US8541590 Proteasome inhibitors and processes for their preparation, purification and use
09/24/2013US8541589 Thioacetate compounds, compositions and methods of use
09/24/2013US8541588 Sulfonamide derivatives
09/24/2013US8541587 Lysophosphatidic acid receptor antagonists
09/24/2013US8541585 N-acyl cyclic amine derivative or pharmaceutically acceptable salt thereof
09/24/2013US8541584 3-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives
09/24/2013US8541579 Substituted diketopiperazines as oxytocin antagonists
09/24/2013US8541576 Substituted pyrazolo-quinazoline derivatives as kinase inhibitors
09/24/2013US8541573 Substituted sulfonamide compounds
09/24/2013US8541476 Compounds for treatment of malignant tumors
09/24/2013US8541475 MAO-B inhibitors useful for treating obesity
09/24/2013US8541474 N,N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same
09/24/2013US8541472 used to sanitize and treat medical/dental equipment including implants, water storage, distribution and treatment facilities, industrial equipment and food preparation and processing equipment; safe, used to prevent/reduce/eliminate infections
09/24/2013US8541471 Water-soluble strontium salts for use in treatment of cartilage and/or bone conditions
09/24/2013US8541470 Topical pharmaceutical formulation
09/24/2013US8541469 Treatment of cell-mediated immune diseases
09/24/2013US8541468 Ophthalmic composition for treating tear dysfunction
09/24/2013US8541467 Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of hematological dyscrasias and cancer of an organ
09/24/2013US8541466 Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
09/24/2013US8541465 Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
09/24/2013US8541464 Treatment of atrial fibrillation
09/24/2013US8541463 Ketorolac tromethamine compositions for treating or preventing ocular pain
09/24/2013US8541462 Tetrahydrocarbazole derivatives as ligands of G-protein coupled receptors
09/24/2013US8541461 Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
09/24/2013US8541460 PDK-1/Akt signaling inhibitors
09/24/2013US8541459 Pharmaceutical composition
09/24/2013US8541458 Oxabicycloheptanes and oxabicycloheptenes, their preparation and use